abstract |
This Invention relates to diaminopyrroloquinazoline compounds of formula (I) wherein R1, R2, R3, Ra, Rb, Rc, Rd, Re, Rf and A are as defined in the description and Claims, which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B, and are useful for lowering blood glucose concentrations in mammals. |